Background: Psychiatric comorbidities are frequent among people who inject drugs, they are associated with a poorer prognosis and need to be addressed. Their interaction with daily heroin injection requires clarification.
Methods: A cross-sectional survey was conducted among PWID recruited in the city of Haiphong, Vietnam, by respondent-driven sampling. The inclusion criteria were age 18 or older and current injection drug use, verified by skin marks and positive urine tests for heroin or methamphetamine. Data on socio-demographic characteristics, drug use, sexual behaviour and access to treatment were collected using face-to-face questionnaires by trained interviewers. PWID were screened by trained psychiatrists for depression, psychotic disorder and suicidality, using the MINI questionnaire.
Results: 418 participants were included in the analyses. All were injected heroin users, 21 % were diagnosed with a current major depressive disorder, 15 % with a current psychotic disorder and 12 % presented a suicide risk. In the bivariate analyses, regular meth use, cannabis use and ketamine use were positively associated with presenting at least one psychiatric condition while daily heroin injection and being currently treated with methadone were negatively associated. In the multivariate model, poly-substance use was positively associated with depression (methamphetamine and drinking in addition to heroin) and psychotic disorder (methamphetamine and/or hazardous drinking in addition to heroin) while daily heroin injection and current methadone treatment were negatively and independently associated with depression and psychotic syndrome.
Conclusions: Our survey confirms the burden of methamphetamine use and the protective effect of methadone but also a possible protective effect of daily heroin injection.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290903 | PMC |
http://dx.doi.org/10.1016/j.drugalcdep.2020.108334 | DOI Listing |
Exp Brain Res
December 2024
Department of Physiology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Heroin addiction is one of the neuropsychiatric burdens that affects many genetic and epigenetic systems. While it is known that heroin may change the expressions of some genes in the brain during dependence, there is no detailed study related to which gene are mostly affected. Therefore, in the current study, we aimed to determine alterations in the miRNA profiles of rats' brains for providing a detailed analysis of molecular mechanisms in heroin addiction-related toxicology.
View Article and Find Full Text PDFBMC Cardiovasc Disord
December 2024
Institute of Cardiology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Subst Use Misuse
December 2024
Department of Social and Behavioral Sciences, School of Global Public Health Health, New York University, USA.
J Addict Med
November 2024
From the Johns Hopkins School of Medicine, Behavioral Pharmacology Research Unit, Baltimore, MD (AS, KED, KS-D, SD, NK, ECS, CB); and Friends Research Institute Baltimore, MD, (AS).
Objective: Illicitly manufactured fentanyl has largely replaced heroin throughout the United States. Characteristics of fentanyl-specific withdrawal are not well understood compared to traditional opioid withdrawal. This study examines opioid withdrawal severity among 2 cohorts of study participants who underwent identical morphine stabilization procedures before and after fentanyl was introduced to the local drug market.
View Article and Find Full Text PDFIndian J Psychol Med
April 2024
Indian Drug Users Forum, New Delhi, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!